Reply on RT–PCR for Detecting Cancer Residual Disease
Author Information
Author(s): Nissan A, Mitrani-Rosenbaum S
Primary Institution: Hadassah-Hebrew University Medical Center
Hypothesis
Can RT–PCR accurately detect minimal residual disease in breast cancer patients?
Conclusion
The study suggests that current PCR methods may yield false positives due to contamination and other factors.
Supporting Evidence
- Activated lymphoid cells are present in cancer patients but do not express certain cancer markers.
- The study used 13 negative controls to assess the specificity of PCR methods.
- None of the markers were expressed in the inflammatory lymph nodes tested.
Takeaway
The study looked at how well a test can find leftover cancer cells, but it found that the test might sometimes show false results.
Methodology
The study used negative controls and lymph nodes from patients with non-cancer conditions to assess the specificity of PCR methods.
Potential Biases
There is a risk of bias due to the possibility of contamination and illegitimate transcription in PCR methods.
Limitations
The study is limited by the small sample size and the potential for false positives in PCR methods.
Participant Demographics
The study included peripheral blood lymphocytes from 10 healthy donors and lymph nodes from patients with other conditions.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website